ImportRefusal LogoImportRefusal

CELL PROCESSING CENTRE

⚠️ Moderate Risk

FEI: 3014208705 • Osaka • JAPAN

FEI

FEI Number

3014208705

📍

Location

Osaka

🇯🇵

Country

JAPAN
🏢

Address

3 34-8, Naturokubo-Cho, Osaka, , Japan

Moderate Risk

FDA Import Risk Assessment

29.9
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

3
Total Refusals
5
Unique Violations
11/30/2020
Latest Refusal
5/14/2018
Earliest Refusal

Score Breakdown

Violation Severity
55.0×40%
Refusal Volume
22.3×30%
Recency
0.0×20%
Frequency
11.8×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

4712×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

22801×

DIRSEXMPT

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
11/30/2020
66VAY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
2280DIRSEXMPT
3280FRNMFGREG
75UNAPPROVED
Division of West Coast Imports (DWCI)
5/14/2018
53YH99OTHER COSMETIC AND COSMETIC PRODUCTS, N.E.C.
471CSTIC LBLG
Division of Northern Border Imports (DNBI)
5/14/2018
53YD99OTHER COSMETIC AND COSMETIC PRODUCTS, N.E.C.
471CSTIC LBLG
Division of Northern Border Imports (DNBI)

Frequently Asked Questions

What is CELL PROCESSING CENTRE's FDA import refusal history?

CELL PROCESSING CENTRE (FEI: 3014208705) has 3 FDA import refusal record(s) in our database, spanning from 5/14/2018 to 11/30/2020.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. CELL PROCESSING CENTRE's FEI number is 3014208705.

What types of violations has CELL PROCESSING CENTRE received?

CELL PROCESSING CENTRE has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about CELL PROCESSING CENTRE come from?

All FDA import refusal data for CELL PROCESSING CENTRE is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.